Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes

Journal of Autoimmunity

Volumn 26, Issue 4, 2006, Pages 225-231

  Ogawa, Norihiko ^a   Minamimura, Keisuke ^a   Kodaka, Tetsuo ^a   Maki, Takashi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti lymphocyte serum; Disease prevention; Immunoregulatory T cells; NOD mice; Type 1 diabetes

Indexed keywords

LYMPHOCYTE ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE TOLERANCE TEST; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOID CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; ISLETS OF LANGERHANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; MICE, SCID; RABBITS; T-LYMPHOCYTES;

EID: 33744505629     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.03.001     Document Type: Article

References (31)

1. Ogawa M., Maruyama T., Hasegawa T., Kanaya T., Kobayashi F., Tochino Y., et al. The inhibitory effect of neonatal thymectomy on the incidence of insulitis on non-obese diabetic (NOD) mice. Biomed Res 6 (1985) 103-108
2. Wicker L.S., Miller B.J., and Mullen Y. Transfer of autoimmune diabetes mellitus with SPC from nonobese diabetic (NOD) mice. Diabetes 35 (1986) 855-859
3. Wang Y., Hao L., Gill R.G., and Lafferty K.J. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36 (1987) 535-538
4. + cells. J Exp Med 166 (1987) 823-832
5. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140 (1988) 52-58
6. - T-lymphocytes in T-lymphocyte-depleted NOD mice. Diabetes 37 (1988) 204-208
7. Shizuru J.A., Taylor-Edwards C., Banks B.A., Gregory A.L., and Fathman C.G. Immunotherapy of the nonobese diabetic mouse treatment with an antibody to T-helper lymphocytes. Science 240 (1988) 659-662
8. Harada M., and Makino S. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1.2 antibody. Exp Anim 35 (1986) 501-504
9. Koike T., Itoh Y., Ishii T., Ito I., Takabayashi K., Maruyama N., et al. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36 (1987) 539-541
10. Charlton B., Bacelj A., and Mandel T.E. Administration of silica particles or anti-Lyt2 antibody prevent beta cell destruction in NOD mice given cyclophosphamide. Diabetes 37 (1988) 930-935
11. Hayward A.R., and Shreiber M. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol 143 (1989) 1555-1559
12. Maki T., Ichikawa T., Blanco R., and Porter J. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 89 (1993) 3434-3438
13. Chatenoud L., Thervet E., Primo J., and Bach J.F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91 (1994) 123-127
14. Ogawa N., List J.F., Habener J., and Maki T. Cure of overt type 1 diabetes in NOD mice by transient treatment with antilymphocyte serum and exendin-4. Diabetes 53 (2004) 1700-1705
15. Li Y., Hansotia T., Yusta B., Ris F., Halban P.A., and Drucker D.J. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 278 (2003) 471-478
16. Xu G., Stoffers A.D., Habener F.J., and Bonner-Weir S. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48 (1999) 2270-2276
17. Tourrel C., Bailbe D., Meile M.-J., Kergoat M., and Portha B. Glucagon-like peptide 1 and exendin-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50 (2001) 1562-1570
18. Monaco A.P., and Wood M.L. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 2 (1970) 489-492
19. Pastorale C., Arata M., Caminos A., Bruno L., Basabe J., and Chemes H. Effect of modified diabetic splenocytes on mice injected with multiple low-dose streptozotocin. Exp Biol Med 227 (2002) 282-289
20. Bonnefoy-Berard N., Vincent C., and Revillard J.P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51 (1991) 669-673
21. Rebellato L.M., Gross U., Verbanac K.M., and Thomas J.M. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 57 (1994) 685-694
22. Merion R.M., Howell T., and Bromberg J.S. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation 65 (1998) 1481-1489
23. Maki T., Gottschalk R., Wood M.L., and Monaco A.P. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol 127 (1981) 1433-1437
24. Chatenoud L., Primo J., and Bach J.F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158 (1997) 2947-2954
25. + regulatory T cells are spared from deletion by anti-lymphocyte serum (ALS), a polyclonal anti-T cell antibody. J Immunol 176 (2006) 4125-4132
26. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
27. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 (2002) 183-191
28. Berzins S.P., Venanzi E.S., Benoist C., and Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes 52 (2003) 327-334
29. Gregori S., Giarratana N., Smiroldo S., and Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171 (2003) 4040-4047
30. Szanya V., Ermann J., Taylor C., Holness C., and Fathman C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes express L-selectin and high levels of CCR7. J Immunol 169 (2002) 2461-2465
31. Becker D.J., LaPorte R.E., Libman I., Pietropaolo M., and Dosch H.-M. Prevention of type 1 diabetes: is now the time?. J Clin Endocrinol Metab 85 (1999) 498-506